Wealth Enhancement Advisory Services
INMB icon

Wealth Enhancement Advisory Services’s INmune Bio INMB Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.7K Buy
+20,449
New +$28.3K ﹤0.01% 3952

Other funds holding INMB

CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Wealth Enhancement Advisory Services's INMB Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in INmune Bio (INMB) in Q2 2026: 20,449 shares worth $39.7K. The stake represents ﹤0.01% of the portfolio and ranks #3952 among its holdings.

8 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

  • Wealth Enhancement Advisory Services held 20,449 shares of INmune Bio worth $39.7K as of Q2 2026.
  • INmune Bio was a new Wealth Enhancement Advisory Services position in Q2 2026.
  • INmune Bio made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3952 holding.
  • 8 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.